FIELD: pharmaceuticals.
SUBSTANCE: invention provides a method of obtaining CD106 positive and/or CD90 positive fibroblasts. Also, the invention provides a cell population of G-CSF-positive fibroblasts and pharmaceutical compositions containing fibroblasts for the treatment of heart diseases.
EFFECT: method of obtaining CD106-positive and/or CD90-positive fibroblasts includes the step of culturing the fibroblasts in the presence of at least one factor selected from the group consisting of TNF-α and IL-4, with an increase in the number of CD106-positive and/or CD90-positive fibroblasts.
3 cl, 9 dwg, 11 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CELLS DERIVED FROM CARDIAC TISSUE | 2010 |
|
RU2662675C1 |
| CELLS DERIVED FROM CARDIAL TISSUE | 2010 |
|
RU2642282C1 |
| CELLS BEING DERIVATIVES OF CARDIAC TISSUE | 2010 |
|
RU2583287C2 |
| METHOD FOR TREATING MYOCARDIAL INFARCTION | 2005 |
|
RU2294206C2 |
| AMNIOTIC ADHESIVE CELLS | 2009 |
|
RU2562154C2 |
| BIOTRANSPLANT AND METHOD FOR TREATING CHRONIC CARDIAC FAILURE (VARIANTS) | 2005 |
|
RU2299073C1 |
| METHOD FOR PRODUCING AND INDUCING TARGETED DIFFERENTIATION OF PULMONARY PLURIPOTENT CELL CULTURE | 2013 |
|
RU2554843C2 |
| METHOD OF CARDIOMYOCYTES CLEANING | 2021 |
|
RU2813532C1 |
| BIOTRANSPLANT, METHOD FOR ITS OBTAINING (VARIANTS) AND METHOD FOR TREATING ISCHEMIC CARDIAC DISEASE | 2004 |
|
RU2268061C1 |
| CELL COMPOSITIONS AND METHODS OF THEIR APPLICATION FOR TREATING CARDIAC TISSUE | 2009 |
|
RU2519762C2 |
